Life expectancy in some CKD patients could be improved with nephron-sparing treatment

A nephron-sparing treatment selection for small renal masses based on the nephrometry score may improve life expectancy in patients with mild or moderate chronic kidney disease, a study published in the August 2016 issue of the American Journal of Roentgenology said.

Led by Stella K. Kang, a radiologist with the Department of Radiology at the New York School of Medicine, the study was designed to compare the effectiveness of a algorithm for small renal tumors incorporating the nephrometry score, a renal tumor anatomy scoring system developed by urologists, with the current standard of uniformly recommended in patients with mild-to-moderate (CKD).

According to the study, in the treatment of small renal tumors, the ideal outcome of both complete oncologic control and preservation of is not presently available. Because partial nephrectomy provides superior oncologic control—sometimes at the expense of renal function loss and increased overall mortality—analysis of how these factors should be weighed may facilitate clearer guidelines for selection among nephron-sparing treatments.

"We provide a framework for incorporating tumor imaging features and renal function into treatment selection, which may help to inform physicians regarding the appropriateness of surgery in patients with CKD," Kang said. "Because most often presents as incidental, small, localized, and often indolent tumors in elderly patients with high rates of CKD and comorbidities, competing nononcologic mortality risks should be carefully considered when counseling patients."

"Particularly in such patients with underlying CKD, our modeling results support the integration of renal tumor anatomic features at cross-sectional imaging into decision making for treatment of small renal masses and may be used to provide a patient-centered framework for selection of optimal candidates for ablative therapy," Kang said.


Explore further

Surveillance beats radical nephrectomy for small masses

More information: Stella K. Kang et al. Tumor Anatomy Scoring and Renal Function for Nephron-Sparing Treatment Selection in Patients With Small Renal Masses: A Microsimulation-Based Decision Analysis, American Journal of Roentgenology (2016). DOI: 10.2214/AJR.15.15823
Citation: Life expectancy in some CKD patients could be improved with nephron-sparing treatment (2016, August 17) retrieved 10 July 2020 from https://medicalxpress.com/news/2016-08-life-ckd-patients-nephron-sparing-treatment.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments